Supreme Court Asks Solicitor General to Opine in Pfizer Alien Torts Case
With corporate America itching for the Supreme Court to rein in use of the Alien Torts Statute for suits alleging overseas wrongdoing, the case that may redefine the parameters of the ATS is shaping up as a battle of ex-Harvard law professors. On Monday the Court asked U.S. Solicitor General Elena Kagan to weigh in on Pfizer Inc. v. Rabi Abdullahi, in which the 2nd Circuit revived the claims of Nigerians who allege they were grievously harmed by a Pfizer drug in a government-approved clinical trial.
